IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.

Tue, 03 Nov 2026 08:00:00 -0500

AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest CryptoCurrencyWire Audio Production as part of its sustained effort to provide specialized content distribution via widespread syndication channels.

CryptoCurrencyWire’s latest audio production features Dr. Vin Menon, CEO of MindWave Innovations Inc. (NYSE American: APUS), a digital asset and technology company providing institutional-grade treasury infrastructure for the digital asset

IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.

Tue, 03 Nov 2026 08:00:00 -0500

Form 3 Apimeds Pharmaceuticals For: Dec 01 Filed by: Sherb Eric Michael

Mon, 02 Nov 2026 12:09:00 -0500

si-local-file:///var/storage/secattach/20261102/27272123.html

Form 3 Apimeds Pharmaceuticals For: Dec 01 Filed by: Menon Vin

Mon, 02 Nov 2026 12:00:00 -0500

si-local-file:///var/storage/secattach/20261102/27272056.html

NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide

Tue, 13 Oct 2026 09:43:00 -0500

MATAWAN, N.J., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – MindWave Innovations Inc. USA ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), today announced that NILA, the native token of the MindChain network, will be available on Pionex (https://www.pionex.com/en/), with trading scheduled to begin on Wednesday, Oct. 14, 2026, at 6 a.m. Eastern Time.

The listing gives eligible users in the jurisdictions served by Pionex a direct, simple route to

NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide

Tue, 13 Oct 2026 09:43:00 -0500

The listing gives eligible users in the jurisdictions served by Pionex a direct, simple route to

Form 8-K Apimeds Pharmaceuticals For: Oct 04

Tue, 13 Oct 2026 09:10:00 -0500

si-local-file:///var/storage/secattach/20261013/27178631.html

MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disc

Fri, 09 Oct 2026 18:00:00 -0500

MATAWAN, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- via IBN – MindWave Innovations Inc. USA ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks for clients in climate finance, sports media and insurance, all running on MindChain.

The three agreements follow the same model. MindWave builds and runs a dedicated network for each client on MindChain and is compensated through contracted fees or equity, together with

MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disc

Fri, 09 Oct 2026 18:00:00 -0500

The three agreements follow the same model. MindWave builds and runs a dedicated network for each client on MindChain and is compensated through contracted fees or equity, together with

Form 8-K Apimeds Pharmaceuticals For: Sep 29

Thu, 01 Oct 2026 09:15:00 -0500

si-local-file:///var/storage/secattach/20261001/27132859.html

Form 8-K Apimeds Pharmaceuticals For: Sep 24

Tue, 29 Sep 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260929/27122690.html

MindWave signs 12-month blockchain deal with Flash Sports & Media

Tue, 29 Sep 2026 08:30:23 -0500

MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has signed a 12-month software development and technology services agreement with Flash Sports & Media Holdings, Inc. (OTC: FLZH) to build and operate FlashChain, a blockchain network for tracking digital broadcasting rights, video assets, and match ticket inventory.

Under the agreement, MindWave will deploy a dedicated subnet for FlashChain on its MindChain Layer-2 infrastructure, operate validator nodes, and issue FLZH the cryptographic keys needed to access the network. Flash Sports & Media will own the FlashChain network, its brand, and its Digital Asset and Ticketing Ledger.

MindWave

MindWave signs 12-month blockchain deal with Flash Sports & Media

Tue, 29 Sep 2026 08:30:23 -0500

MindWave

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

Tue, 29 Sep 2026 08:30:00 -0500

MATAWAN, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- MindWave Innovations Inc. ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has signed a 12-month software development and technology services agreement with New York-based Flash Sports & Media Holdings, Inc. (FLZH) to build and operate FlashChain, a blockchain for tracking digital broadcasting rights, video assets and match ticket inventory.

Under the agreement, MindWave will deploy a dedicated subnet for FlashChain on MindChain's Layer-2 infrastructure, operate the validator nodes that run it, and issue

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

Tue, 29 Sep 2026 08:30:00 -0500

Under the agreement, MindWave will deploy a dedicated subnet for FlashChain on MindChain's Layer-2 infrastructure, operate the validator nodes that run it, and issue

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

Tue, 29 Sep 2026 08:30:00 -0500

Under the agreement, MindWave will deploy a dedicated subnet for FlashChain on MindChain's Layer-2 infrastructure, operate the validator nodes that run it, and issue

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

Tue, 29 Sep 2026 08:30:00 -0500

Under the agreement, MindWave will deploy a dedicated subnet for FlashChain on MindChain's Layer-2 infrastructure, operate the validator nodes that run it, and issue

Form 8-K Apimeds Pharmaceuticals For: Jul 24

Wed, 23 Sep 2026 06:02:00 -0500

si-local-file:///var/storage/secattach/20260923/27092858.html

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

Fri, 18 Sep 2026 14:00:00 -0500

AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.

MindWave Innovations, a wholly owned subsidiary of Apimeds Pharmaceuticals US, is developing institutional digital asset infrastructure connecting treasury, insurance, tokenized assets and blockchain ecosystems. Its platform combines insured custody, transparent reporting and technology-driven portfolio management to support risk-aware yield on Bitcoin reserves and institutional participation in

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

Fri, 18 Sep 2026 14:00:00 -0500

Form 8-K Apimeds Pharmaceuticals For: Sep 10

Fri, 11 Sep 2026 09:11:00 -0500

si-local-file:///var/storage/secattach/20260911/27051201.html

Form 8-K Apimeds Pharmaceuticals For: Aug 19

Fri, 21 Aug 2026 17:13:00 -0500

si-local-file:///var/storage/secattach/20260821/26962399.html

Form 8-K Apimeds Pharmaceuticals For: Aug 19

Fri, 21 Aug 2026 17:13:00 -0500

si-local-file:///var/storage/secattach/20260821/26962399.html

Form 10-Q Apimeds Pharmaceuticals For: Jun 30

Fri, 14 Aug 2026 16:29:00 -0500

si-local-file:///var/storage/secattach/20260814/26931267.html

Form 10-Q Apimeds Pharmaceuticals For: Jun 30

Fri, 14 Aug 2026 16:29:00 -0500

si-local-file:///var/storage/secattach/20260814/26931267.html

StreetInsider.com News Articles

IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.

IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.

Form 3 Apimeds Pharmaceuticals For: Dec 01 Filed by: Sherb Eric Michael

Form 3 Apimeds Pharmaceuticals For: Dec 01 Filed by: Menon Vin

NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide

NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide

Form 8-K Apimeds Pharmaceuticals For: Oct 04

MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disc

MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disc

Form 8-K Apimeds Pharmaceuticals For: Sep 29

Form 8-K Apimeds Pharmaceuticals For: Sep 24

MindWave signs 12-month blockchain deal with Flash Sports & Media

MindWave signs 12-month blockchain deal with Flash Sports & Media

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media

Form 8-K Apimeds Pharmaceuticals For: Jul 24

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.

Form 8-K Apimeds Pharmaceuticals For: Sep 10

Form 8-K Apimeds Pharmaceuticals For: Aug 19

Form 8-K Apimeds Pharmaceuticals For: Aug 19

Form 10-Q Apimeds Pharmaceuticals For: Jun 30

Form 10-Q Apimeds Pharmaceuticals For: Jun 30